Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-Lactamase-producing Escherichia coli and Klebsiella pneumoniae

Microbial Drug Resistance

Volumn 18, Issue 5, 2012, Pages 518-524

  Park, So Yeon ^a   Kang, Cheol In ^a   Joo, Eun Jeong ^a   Ha, Young Eun ^a   Wi, Yu Mi ^a   Chung, Doo Ryeon ^a   Peck, Kyong Ran ^a   Lee, Nam Yong ^a   Song, Jae Hoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE CTX M; BETA LACTAMASE INHIBITOR; BETA LACTAMASE SHV; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMMUNOSUPPRESSIVE AGENT; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK ASSESSMENT; RISK FACTOR; TUBE; URINARY TRACT INFECTION;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CASE-CONTROL STUDIES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 84866524561     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2012.0067     Document Type: Article

References (28)

1. Bhusal, Y., C.N. Mihu, J.J. Tarrand, and K.V. Rolston. 2011. Incidence of fluoroquinolone-resistant and extendedspectrum beta-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States. Chemotherapy 57:335-338.
2. Charlson, M.E., P. Pompei, K.L. Ales, and C.R. MacKenzie. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383. (Pubitemid 17055592)
3. Chow, J.W., M.J. Fine, D.M. Shlaes, J.P. Quinn, D.C. Hooper, M.P. Johnson, R. Ramphal, M.M. Wagener, D.K. Miyashiro, and V.L. Yu. 1991. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med. 115:585-590.
4. Chow, J.W., and V.L. Yu. 1999. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int. J. Antimicrob. Agents 11:7-12. (Pubitemid 29067411)
5. Chung, D.R., H.R. Lee, S.S. Lee, S.W. Kim, H.H. Chang, S.I. Jung, M.D. Oh, K.S. Ko, C.I. Kang, K.R. Peck, et al. 2008. Evidence for clonal dissemination of the serotype K1 Klebsiella pneumoniae strain causing invasive liver abscesses in Korea. J. Clin. Microbiol. 46:4061-4063.
6. Garner, J.S., W.R. Jarvis, T.G. Emori, T.C. Horan, and J.M. Hughes. 1988. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 16:128-140.
7. Giufre, M., C. Graziani, M. Accogli, I. Luzzi, L. Busani, and M. Cerquetti. 2012. Escherichia coli of human and avian origin: detection of clonal groups associated with fluoroquinolone and multidrug resistance in Italy. J. Antimicrob. Chemother. 67:860-867.
8. Harris, A.D., M.H. Samore, M. Lipsitch, K.S. Kaye, E. Perencevich, and Y. Carmeli. 2002. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin. Infect. Dis. 34:1558-1563. (Pubitemid 34615439)
9. Hyle, E.P., A.D. Lipworth, T.E. Zaoutis, I. Nachamkin, N.O. Fishman, W.B. Bilker, X. Mao, and E. Lautenbach. 2005. Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. Clin. Infect. Dis. 40:1317-1324. (Pubitemid 40570242)
10. Kim, J., Y.M. Lim, I. Rheem, Y. Lee, J.C. Lee, S.Y. Seol, Y.C. Lee, and D.T. Cho. 2005. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea. FEMS Microbiol. Lett. 245:93-98. (Pubitemid 40410682)
11. Kopterides, P., P.K. Koletsi, A. Michalopoulos, and M.E. Falagas. 2007. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates. Int. J. Antimicrob. Agents 30:409-414. (Pubitemid 47498964)
12. Kritsotakis, E.I., C. Tsioutis, M. Roumbelaki, A. Christidou, and A. Gikas. 2011. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamaseproducing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J. Antimicrob. Chemother. 66:1383-1391.
13. Lee, H.Y., C.L. Chen, S.B. Wang, L.H. Su, S.H. Chen, S.Y. Liu, T.L. Wu, T.Y. Lin, and C.H. Chiu. 2011. Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications. Int. J. Antimicrob. Agents 37:302-308.
14. Lin, C.J., L.K. Siu, L. Ma, Y.T. Chang, and P.L. Lu. 2012. Molecular epidemiology of ciprofloxacin-resistant extendedspectrum beta-lactamase- producing Klebsiella pneumoniae in Taiwan. Microb. Drug Resist. 18:52-58.
15. Mermel, L.A., M. Allon, E. Bouza, D.E. Craven, P. Flynn, N.P. O'Grady, I.I. Raad, B.J. Rijnders, R.J. Sherertz, and D.K. Warren. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49:1-45.
16. Mosqueda-Gomez, J.L., A. Montano-Loza, A.L. Rolon, C. Cervantes, J.M. Bobadilla-del-Valle, J. Silva-Sanchez, U. Garza-Ramos, A. Villasis-Keever, A. Galindo-Fraga, G.M. Palacios, et al. 2008. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study. Int. J. Infect. Dis. 12:653-659.
17. Paramythiotou, E., J.C. Lucet, J.F. Timsit, D. Vanjak, C. Paugam-Burtz, J.L. Trouillet, S. Belloc, N. Kassis, A. Karabinis, and A. Andremont. 2004. Acquisition of multidrugresistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin. Infect. Dis. 38:670-677. (Pubitemid 38333863)
18. Paterson D.L., Ko W.C., Von Gottberg A., Mohapatra S., Casellas J.M., Goossens H., Mulazimoglu L., Trenholme G., Klugman K.P., Bonomo R.A. and others. 2004. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin. Infect. Dis. 39:31-37. (Pubitemid 38879546)
19. Pitout, J.D. 2008. Multiresistant Enterobacteriaceae: new threat of an old problem. Exp. Rev. Anti. Infect. Ther. 6: 657-669.
20. Rangaraj, G., B.P. Granwehr, Y. Jiang, R. Hachem, and I Raad. 2010. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer 116:967-973.
21. Reuter, S., W.V. Kern, A. Sigge, H. Dohner, R. Marre, P. Kern, and H. von Baum. 2005. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. Clin. Infect. Dis. 40:1087-1093. (Pubitemid 40490230)
22. Rodriguez-Avial, C., I. Rodriguez-Avial, P. Merino, and J.J. Picazo. 2012. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient. Clin. Microbiol. Infect. 18:61-66.
23. Schwaber, M.J., S. Navon-Venezia, D. Schwartz, and Y. Carmeli. 2005. High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase- producing Enterobacteriaceae. Antimicrob. Agents Chemother. 49:2137-2139. (Pubitemid 40631641)
24. Serefhanoglu, K., H. Turan, F.E. Timurkaynak, and H. Arslan. 2009. Bloodstream infections caused by ESBLproducing E. coli and K. pneumoniae: risk factors for multidrug-resistance. Braz. J. Infect. Dis. 13:403-407.
25. Simner, P.J., G.G. Zhanel, J. Pitout, F. Tailor, M. McCracken, M.R. Mulvey, P.R. Lagace-Wiens, H.J. Adam, and D.J. Hoban. 2011. Prevalence and characterization of extended-spectrum beta-lactamase-and AmpC betalactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study. Diagn. Microbiol. Infect Dis. 69:326-334.
26. Tenover, F.C., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
27. Villers, D., E. Espaze, M. Coste-Burel, F. Giauffret, E. Ninin, F. Nicolas, and H. Richet. 1998. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann. Intern. Med. 129:182-189. (Pubitemid 28377507)
28. Wiener, J., J.P. Quinn, P.A. Bradford, R.V. Goering, C. Nathan, K. Bush, and R.A. Weinstein. 1999. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281:517-523. (Pubitemid 29081304)